News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
4h
Green Matters on MSNCOVID-19 Vaccine Deemed Safe Long Term in New Study, Most Common Side Effects RevealedA half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results